Candida auris, a rapidly spreading, multidrug-resistant fungus, poses a formidable global health threat, particularly in healthcare environments. This yeast-type fungus, first identified in Japan in 2009, can cause severe illnesses, thereby demanding meticulous attention from infection preventionists in healthcare settings. Though prevalent, misinformation and assumptions surround Candida auris necessitate debunking to safeguard institutions and patients effectively. This article illuminates the falsities encircling Candida auris, backing up with facts and expert tips to strengthen the fight against this pathogen.
Contrary to the common myth, Candida auris doesn’t merely constitute another species of Candida. Despite belonging to the same genus, its traits significantly differ. The fungus portrays an alarming resistance to diverse classes of antifungal drugs, making conventional treatments futile. In addition, it survives on surfaces and medical tools for extended periods, accentuating its spread within healthcare environments barring appropriate disinfectant application. The transmission method of C. auris, which possibly includes direct and indirect contact, requires the execution of contact precautions, distinguishing it from other Candida species. Hence, infection preventionists are recommended to regard C. auris as a distinct multidrug-resistant organism and enact reinforced infection control precautions alongside consistent communication between hospital departments.
Another myth to debunk is considering only immunocompromised patients at risk. Though patients undergoing transplant procedures, cancer treatments, or immunosuppressive therapy are at an increased risk, non-immunocompromised patients can also contract Candida auris. Of particular concern is the colonization possibility where patients carry Candida auris on their skin without symptoms, becoming unwitting spreaders of the fungal pathogen.
Contradicting a common misbelief, the indispensability of hand hygiene extends to all fungal pathogens, including Candida auris. Effectually conducted hand hygiene, employing alcohol-based hand rubs, stands as a potent protective measure against pathogen spread. Alongside practicing appropriate hand hygiene, infection preventionists should ensure that all disinfectants used align with the US Environmental Protection Agency’s List P, designed explicitly for combating C. auris.
While outbreak management is crucial, proactive screening and surveillance are considered more efficient approaches to prevent multi-patient or cross-hospital transmissions. It is pivotal to establish admission screening criteria, particularly for patients with higher risk factors. Furthermore, repeated surveillance cultures and strict precaution adherence are vital to prevent wide-scale outbreaks arising from persistent colonization, despite apparent clinical resolution.
Lastly, although Candida auris mirrors various other Candida species in culture, it demands specialist methods for distinguishing it. Their similar behavior poses a diagnostic challenge as numerous lab systems struggle to identify C. auris properly, thereby delaying suitable treatment and preventive measures.
In summary, while eager vigilance is necessary to combat Candida auris effectively, debunking myths surrounding the pathogen is crucial. Understanding its distinctive characteristics will allow healthcare workers to implement evidence-based action to manage its spread, emphasizing the role of infection preventionists in education and prevention measure reinforcement.
Source: https://www.infectioncontroltoday.com/view/stop-spread-c-auris-know-myths-follow-science